

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of protein localization to cell surface (GO:2000009) | 7.16726947 |
| 2 | regulation of sarcomere organization (GO:0060297) | 7.03386531 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.81831303 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.81831303 |
| 5 | ribonucleoprotein complex disassembly (GO:0032988) | 6.77391818 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.19433970 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 6.19433970 |
| 8 | organelle disassembly (GO:1903008) | 6.06872973 |
| 9 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 5.98034081 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 5.94908856 |
| 11 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 5.75750704 |
| 12 | regulation of skeletal muscle contraction (GO:0014819) | 5.69790825 |
| 13 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 5.65124970 |
| 14 | negative regulation of muscle hypertrophy (GO:0014741) | 5.52309497 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.28481462 |
| 16 | cysteine metabolic process (GO:0006534) | 5.11968012 |
| 17 | tryptophan catabolic process (GO:0006569) | 5.11302865 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 5.11302865 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 5.11302865 |
| 20 | plasma membrane repair (GO:0001778) | 5.11222515 |
| 21 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.10026026 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.88020387 |
| 23 | membrane raft organization (GO:0031579) | 4.83724564 |
| 24 | bile acid biosynthetic process (GO:0006699) | 4.74347494 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.70149775 |
| 26 | fatty acid elongation (GO:0030497) | 4.69545904 |
| 27 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.64777050 |
| 28 | kynurenine metabolic process (GO:0070189) | 4.64595198 |
| 29 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 4.60927368 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.40262985 |
| 31 | primary alcohol catabolic process (GO:0034310) | 4.32481913 |
| 32 | muscle cell cellular homeostasis (GO:0046716) | 4.28975610 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.28327601 |
| 34 | urea cycle (GO:0000050) | 4.24566674 |
| 35 | urea metabolic process (GO:0019627) | 4.24566674 |
| 36 | negative regulation of heart growth (GO:0061117) | 4.23813774 |
| 37 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.23813774 |
| 38 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.22770563 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.19909513 |
| 40 | lysine catabolic process (GO:0006554) | 4.15715430 |
| 41 | lysine metabolic process (GO:0006553) | 4.15715430 |
| 42 | glycerophospholipid catabolic process (GO:0046475) | 4.09763287 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.07369600 |
| 44 | bile acid metabolic process (GO:0008206) | 4.06012510 |
| 45 | amine catabolic process (GO:0009310) | 4.00486570 |
| 46 | cellular biogenic amine catabolic process (GO:0042402) | 4.00486570 |
| 47 | sulfur amino acid catabolic process (GO:0000098) | 3.97820069 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 3.92998169 |
| 49 | membrane budding (GO:0006900) | 3.92127234 |
| 50 | alpha-linolenic acid metabolic process (GO:0036109) | 3.90118950 |
| 51 | complement activation, alternative pathway (GO:0006957) | 3.85666488 |
| 52 | high-density lipoprotein particle remodeling (GO:0034375) | 3.84755111 |
| 53 | urate metabolic process (GO:0046415) | 3.83462398 |
| 54 | ketone body metabolic process (GO:1902224) | 3.82159887 |
| 55 | synapsis (GO:0007129) | 3.81455425 |
| 56 | regulation of action potential (GO:0098900) | 3.81374684 |
| 57 | coenzyme catabolic process (GO:0009109) | 3.78557983 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 3.74372581 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 3.73758024 |
| 60 | serine family amino acid catabolic process (GO:0009071) | 3.71962259 |
| 61 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.69420444 |
| 62 | short-chain fatty acid metabolic process (GO:0046459) | 3.67597094 |
| 63 | regulation of protein activation cascade (GO:2000257) | 3.67235358 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 3.66768901 |
| 65 | regulation of triglyceride catabolic process (GO:0010896) | 3.65327756 |
| 66 | negative regulation of monooxygenase activity (GO:0032769) | 3.64516423 |
| 67 | protein carboxylation (GO:0018214) | 3.64378909 |
| 68 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.64378909 |
| 69 | drug catabolic process (GO:0042737) | 3.63697368 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 3.63294947 |
| 71 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 3.60597036 |
| 72 | very long-chain fatty acid metabolic process (GO:0000038) | 3.60126832 |
| 73 | platelet dense granule organization (GO:0060155) | 3.59000068 |
| 74 | transcytosis (GO:0045056) | 3.58683988 |
| 75 | amino-acid betaine metabolic process (GO:0006577) | 3.57620346 |
| 76 | regulation of p38MAPK cascade (GO:1900744) | 3.56318531 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 3.50525255 |
| 78 | homocysteine metabolic process (GO:0050667) | 3.50238360 |
| 79 | cytoplasmic microtubule organization (GO:0031122) | 3.49749352 |
| 80 | branched-chain amino acid catabolic process (GO:0009083) | 3.49484258 |
| 81 | cofactor catabolic process (GO:0051187) | 3.49232310 |
| 82 | triglyceride homeostasis (GO:0070328) | 3.48915786 |
| 83 | acylglycerol homeostasis (GO:0055090) | 3.48915786 |
| 84 | negative regulation of organelle assembly (GO:1902116) | 3.48215080 |
| 85 | regulation of fibrinolysis (GO:0051917) | 3.47966720 |
| 86 | membrane assembly (GO:0071709) | 3.47498574 |
| 87 | reverse cholesterol transport (GO:0043691) | 3.47412822 |
| 88 | positive regulation of microtubule polymerization (GO:0031116) | 3.46651706 |
| 89 | aspartate family amino acid catabolic process (GO:0009068) | 3.44622119 |
| 90 | drug transmembrane transport (GO:0006855) | 3.44535723 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.43485246 |
| 92 | regulation of complement activation (GO:0030449) | 3.43429470 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.43346431 |
| 94 | intraciliary transport (GO:0042073) | 3.41635159 |
| 95 | fatty acid beta-oxidation (GO:0006635) | 3.39000596 |
| 96 | serine family amino acid biosynthetic process (GO:0009070) | 3.38537431 |
| 97 | regulation of meiosis I (GO:0060631) | 3.38417008 |
| 98 | fatty acid oxidation (GO:0019395) | 3.36589732 |
| 99 | cholesterol efflux (GO:0033344) | 3.35928932 |
| 100 | bile acid and bile salt transport (GO:0015721) | 3.35456222 |
| 101 | central nervous system myelination (GO:0022010) | 3.33732762 |
| 102 | axon ensheathment in central nervous system (GO:0032291) | 3.33732762 |
| 103 | plasma lipoprotein particle clearance (GO:0034381) | 3.31502264 |
| 104 | cellular glucuronidation (GO:0052695) | 3.30469909 |
| 105 | cholesterol biosynthetic process (GO:0006695) | 3.30464477 |
| 106 | lipid oxidation (GO:0034440) | 3.29640782 |
| 107 | fatty acid catabolic process (GO:0009062) | 3.29072044 |
| 108 | response to nitrosative stress (GO:0051409) | 3.29008272 |
| 109 | protein-lipid complex remodeling (GO:0034368) | 3.28911154 |
| 110 | macromolecular complex remodeling (GO:0034367) | 3.28911154 |
| 111 | plasma lipoprotein particle remodeling (GO:0034369) | 3.28911154 |
| 112 | phospholipid efflux (GO:0033700) | 3.28686531 |
| 113 | aldehyde catabolic process (GO:0046185) | 3.28678441 |
| 114 | postreplication repair (GO:0006301) | 3.28561198 |
| 115 | heme transport (GO:0015886) | 3.27978448 |
| 116 | benzene-containing compound metabolic process (GO:0042537) | 3.26953005 |
| 117 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.25588128 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.25588128 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 3.21724772 |
| 120 | organic acid catabolic process (GO:0016054) | 3.21724772 |
| 121 | negative regulation of cardiac muscle tissue development (GO:0055026) | 3.17833250 |
| 122 | ethanol oxidation (GO:0006069) | 3.17275182 |
| 123 | S-adenosylmethionine metabolic process (GO:0046500) | 3.14053802 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 3.12945296 |
| 125 | monocarboxylic acid catabolic process (GO:0072329) | 3.12011631 |
| 126 | thioester metabolic process (GO:0035383) | 3.11888703 |
| 127 | acyl-CoA metabolic process (GO:0006637) | 3.11888703 |
| 128 | opsonization (GO:0008228) | 3.10384425 |
| 129 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.09834636 |
| 130 | regulation of cholesterol metabolic process (GO:0090181) | 3.08939552 |
| 131 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.08896587 |
| 132 | piRNA metabolic process (GO:0034587) | 3.07562306 |
| 133 | branched-chain amino acid metabolic process (GO:0009081) | 3.05188847 |
| 134 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.04789060 |
| 135 | regulation of cilium movement (GO:0003352) | 3.02821797 |
| 136 | arginine metabolic process (GO:0006525) | 3.02691050 |
| 137 | glucuronate metabolic process (GO:0019585) | 3.02460708 |
| 138 | uronic acid metabolic process (GO:0006063) | 3.02460708 |
| 139 | heart process (GO:0003015) | 3.01126330 |
| 140 | heart contraction (GO:0060047) | 3.01126330 |
| 141 | ethanol metabolic process (GO:0006067) | 3.00978421 |
| 142 | regulation of protein localization to cell surface (GO:2000008) | 3.00283552 |
| 143 | polyol biosynthetic process (GO:0046173) | 2.96830894 |
| 144 | resolution of meiotic recombination intermediates (GO:0000712) | 2.95462942 |
| 145 | proteasome assembly (GO:0043248) | 2.91100818 |
| 146 | positive regulation of actin filament depolymerization (GO:0030836) | 2.87615124 |
| 147 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.86894211 |
| 148 | histone H2A acetylation (GO:0043968) | 2.81154179 |
| 149 | mitochondrial DNA replication (GO:0006264) | 2.78226964 |
| 150 | positive regulation of TOR signaling (GO:0032008) | 2.77424073 |
| 151 | regulation of muscle hypertrophy (GO:0014743) | 2.76631593 |
| 152 | peroxisome organization (GO:0007031) | 2.73784674 |
| 153 | lipid particle organization (GO:0034389) | 2.71542998 |
| 154 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.67058337 |
| 155 | fibroblast migration (GO:0010761) | 2.66586680 |
| 156 | valine metabolic process (GO:0006573) | 2.65546523 |
| 157 | regulation of membrane repolarization (GO:0060306) | 2.64779689 |
| 158 | negative regulation of cell size (GO:0045792) | 2.61162757 |
| 159 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.59710656 |
| 160 | protein K11-linked ubiquitination (GO:0070979) | 2.57996717 |
| 161 | vascular smooth muscle contraction (GO:0014829) | 2.56523447 |
| 162 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.53771885 |
| 163 | negative regulation of organ growth (GO:0046621) | 2.52952959 |
| 164 | oxidative demethylation (GO:0070989) | 2.51972749 |
| 165 | sterol biosynthetic process (GO:0016126) | 2.50871647 |
| 166 | cullin deneddylation (GO:0010388) | 2.49690639 |
| 167 | regulation of cardioblast proliferation (GO:0003264) | 2.48457265 |
| 168 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.48457265 |
| 169 | regulation of calcium ion import (GO:0090279) | 2.45358328 |
| 170 | protein localization to cilium (GO:0061512) | 2.44764677 |
| 171 | phospholipid homeostasis (GO:0055091) | 2.44246721 |
| 172 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.43409020 |
| 173 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.43409020 |
| 174 | prenylation (GO:0097354) | 2.42822177 |
| 175 | protein prenylation (GO:0018342) | 2.42822177 |
| 176 | COPII vesicle coating (GO:0048208) | 2.38890934 |
| 177 | striated muscle atrophy (GO:0014891) | 2.38526573 |
| 178 | protein deneddylation (GO:0000338) | 2.36415275 |
| 179 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.34396322 |
| 180 | C-terminal protein lipidation (GO:0006501) | 2.33773003 |
| 181 | primary alcohol metabolic process (GO:0034308) | 2.33194837 |
| 182 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.32855249 |
| 183 | muscle atrophy (GO:0014889) | 2.31489026 |
| 184 | male meiosis I (GO:0007141) | 2.31086496 |
| 185 | adenosine metabolic process (GO:0046085) | 2.30357085 |
| 186 | epithelial cilium movement (GO:0003351) | 2.28807318 |
| 187 | positive regulation of receptor-mediated endocytosis (GO:0048260) | 2.28355143 |
| 188 | metallo-sulfur cluster assembly (GO:0031163) | 2.26547539 |
| 189 | iron-sulfur cluster assembly (GO:0016226) | 2.26547539 |
| 190 | peroxisome fission (GO:0016559) | 2.25873591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.73841627 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.58196187 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.48692854 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.42311001 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.40288365 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.65014185 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.61078373 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.37370821 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.29612017 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.11076431 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.08466588 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.60053746 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.59506215 |
| 14 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.55575548 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.26378079 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.13515270 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.13400975 |
| 18 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.10581561 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.06640317 |
| 20 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01079686 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 1.83698970 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80118414 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.76659654 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 1.74474257 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.73594692 |
| 26 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.73376189 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71679332 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70394856 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.62236298 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.62155549 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62112480 |
| 32 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.62087032 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58489111 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57887256 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55348363 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52867659 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51333069 |
| 38 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49911500 |
| 39 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.49553059 |
| 40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46672505 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45680125 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44697268 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43991015 |
| 44 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.43896147 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41474640 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40453742 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40262103 |
| 48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39801190 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.37730149 |
| 50 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34706297 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32926330 |
| 52 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.30445776 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30176040 |
| 54 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.29190423 |
| 55 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27367292 |
| 56 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27306378 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26866540 |
| 58 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.25154377 |
| 59 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24881512 |
| 60 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24615033 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24527770 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23456764 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23456764 |
| 64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22973034 |
| 65 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.22922012 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22911839 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21970560 |
| 68 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21428825 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20138606 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19179557 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18760507 |
| 72 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.18537503 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17845471 |
| 74 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.17463451 |
| 75 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17177006 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16311182 |
| 77 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.14594610 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14548859 |
| 79 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.13736183 |
| 80 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11666043 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10507958 |
| 82 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10498723 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10478090 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09963635 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09704916 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.09559198 |
| 87 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08973683 |
| 88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08458010 |
| 89 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06286021 |
| 90 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06273678 |
| 91 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.06224924 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05794783 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05490176 |
| 94 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05134074 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04763824 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04108573 |
| 97 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03610810 |
| 98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03544611 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02881761 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02881761 |
| 101 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.02091337 |
| 102 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01253623 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01088611 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00926711 |
| 105 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99897475 |
| 106 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99809609 |
| 107 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98871520 |
| 108 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98871520 |
| 109 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98337353 |
| 110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97586745 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97397400 |
| 112 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.97228142 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97196351 |
| 114 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.96288545 |
| 115 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95875144 |
| 116 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95302911 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94652557 |
| 118 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93412789 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.92574306 |
| 120 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.91953527 |
| 121 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.90413352 |
| 122 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89902368 |
| 123 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.89900396 |
| 124 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89374457 |
| 125 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88772453 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88705345 |
| 127 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87949797 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87172071 |
| 129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.87133246 |
| 130 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86804272 |
| 131 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85775117 |
| 132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84982825 |
| 133 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.84482679 |
| 134 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.84045467 |
| 135 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82568657 |
| 136 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82544106 |
| 137 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82308855 |
| 138 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.81857832 |
| 139 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81039371 |
| 140 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80312591 |
| 141 | CBP_21632823_ChIP-Seq_H3396_Human | 0.80277448 |
| 142 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.80140752 |
| 143 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.79533657 |
| 144 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.79384171 |
| 145 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.79076876 |
| 146 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.78591335 |
| 147 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.77727783 |
| 148 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.77360093 |
| 149 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.76660169 |
| 150 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.76595446 |
| 151 | NFYA_21822215_ChIP-Seq_K562_Human | 0.75692178 |
| 152 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.75506241 |
| 153 | AR_20517297_ChIP-Seq_VCAP_Human | 0.75049101 |
| 154 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.73779415 |
| 155 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.73463801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.79194433 |
| 2 | MP0005360_urolithiasis | 6.24112203 |
| 3 | MP0005365_abnormal_bile_salt | 4.93464782 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.70625206 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.15091656 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.14176040 |
| 7 | MP0005451_abnormal_body_composition | 3.72441995 |
| 8 | MP0003195_calcinosis | 3.07413641 |
| 9 | MP0002009_preneoplasia | 2.99612155 |
| 10 | MP0000749_muscle_degeneration | 2.87822656 |
| 11 | MP0009840_abnormal_foam_cell | 2.80678593 |
| 12 | MP0005332_abnormal_amino_acid | 2.76170113 |
| 13 | MP0003252_abnormal_bile_duct | 2.64585488 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.63689804 |
| 15 | MP0002638_abnormal_pupillary_reflex | 2.42873870 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.37137526 |
| 17 | MP0008789_abnormal_olfactory_epithelium | 2.35961598 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.35274204 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.23864867 |
| 20 | MP0003718_maternal_effect | 2.19829593 |
| 21 | MP0005083_abnormal_biliary_tract | 2.12149227 |
| 22 | MP0005408_hypopigmentation | 2.08385473 |
| 23 | MP0006054_spinal_hemorrhage | 1.98977211 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.91556330 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.86870200 |
| 26 | MP0003690_abnormal_glial_cell | 1.85256100 |
| 27 | MP0004272_abnormal_basement_membrane | 1.80234484 |
| 28 | MP0003828_pulmonary_edema | 1.74702615 |
| 29 | MP0000609_abnormal_liver_physiology | 1.72302144 |
| 30 | MP0005248_abnormal_Harderian_gland | 1.70439351 |
| 31 | MP0003186_abnormal_redox_activity | 1.69778595 |
| 32 | MP0005187_abnormal_penis_morphology | 1.69725010 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.67739667 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66592748 |
| 35 | MP0009697_abnormal_copulation | 1.65239764 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.64453543 |
| 37 | MP0003868_abnormal_feces_composition | 1.62257793 |
| 38 | MP0004147_increased_porphyrin_level | 1.61814691 |
| 39 | MP0005499_abnormal_olfactory_system | 1.61759073 |
| 40 | MP0005394_taste/olfaction_phenotype | 1.61759073 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.59752561 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.58743274 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.58405886 |
| 44 | MP0000920_abnormal_myelination | 1.57665480 |
| 45 | MP0005367_renal/urinary_system_phenotyp | 1.57648859 |
| 46 | MP0000516_abnormal_urinary_system | 1.57648859 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.56198953 |
| 48 | MP0001984_abnormal_olfaction | 1.55800805 |
| 49 | MP0000751_myopathy | 1.49684155 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.49683644 |
| 51 | MP0004883_abnormal_blood_vessel | 1.46714032 |
| 52 | MP0003329_amyloid_beta_deposits | 1.45696947 |
| 53 | MP0001764_abnormal_homeostasis | 1.43922596 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.42777840 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.42470521 |
| 56 | MP0000647_abnormal_sebaceous_gland | 1.42190177 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.40792614 |
| 58 | MP0005253_abnormal_eye_physiology | 1.36071288 |
| 59 | MP0002909_abnormal_adrenal_gland | 1.35784423 |
| 60 | MP0004043_abnormal_pH_regulation | 1.33262254 |
| 61 | MP0000604_amyloidosis | 1.30687235 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.25171243 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.24490295 |
| 64 | MP0000566_synostosis | 1.23795155 |
| 65 | MP0003950_abnormal_plasma_membrane | 1.22349932 |
| 66 | MP0002972_abnormal_cardiac_muscle | 1.20829492 |
| 67 | MP0005395_other_phenotype | 1.20591150 |
| 68 | MP0005670_abnormal_white_adipose | 1.20527654 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.19488385 |
| 70 | MP0001879_abnormal_lymphatic_vessel | 1.18793260 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 1.17958112 |
| 72 | MP0005330_cardiomyopathy | 1.17475798 |
| 73 | MP0008058_abnormal_DNA_repair | 1.17234497 |
| 74 | MP0005645_abnormal_hypothalamus_physiol | 1.16843926 |
| 75 | MP0002160_abnormal_reproductive_system | 1.15634649 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 1.14677050 |
| 77 | MP0003011_delayed_dark_adaptation | 1.13639567 |
| 78 | MP0005647_abnormal_sex_gland | 1.13278446 |
| 79 | MP0002876_abnormal_thyroid_physiology | 1.11620896 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 1.11555239 |
| 81 | MP0003646_muscle_fatigue | 1.11350664 |
| 82 | MP0010368_abnormal_lymphatic_system | 1.07621641 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.07222246 |
| 84 | MP0000427_abnormal_hair_cycle | 1.05498125 |
| 85 | MP0000639_abnormal_adrenal_gland | 1.05470265 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 1.05015635 |
| 87 | MP0004484_altered_response_of | 1.04013034 |
| 88 | MP0005646_abnormal_pituitary_gland | 1.03408025 |
| 89 | MP0005058_abnormal_lysosome_morphology | 1.03184630 |
| 90 | MP0004381_abnormal_hair_follicle | 1.01283912 |
| 91 | MP0002163_abnormal_gland_morphology | 1.00678884 |
| 92 | MP0009764_decreased_sensitivity_to | 1.00018537 |
| 93 | MP0006276_abnormal_autonomic_nervous | 0.99970980 |
| 94 | MP0001529_abnormal_vocalization | 0.98335961 |
| 95 | MP0001905_abnormal_dopamine_level | 0.95750218 |
| 96 | MP0002090_abnormal_vision | 0.93226578 |
| 97 | MP0005164_abnormal_response_to | 0.93163000 |
| 98 | MP0002233_abnormal_nose_morphology | 0.92407977 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.92263739 |
| 100 | MP0009763_increased_sensitivity_to | 0.92124401 |
| 101 | MP0008469_abnormal_protein_level | 0.90647241 |
| 102 | MP0003786_premature_aging | 0.89297743 |
| 103 | MP0002269_muscular_atrophy | 0.88959000 |
| 104 | MP0002751_abnormal_autonomic_nervous | 0.87930607 |
| 105 | MP0002971_abnormal_brown_adipose | 0.86800514 |
| 106 | MP0005385_cardiovascular_system_phenoty | 0.85114657 |
| 107 | MP0001544_abnormal_cardiovascular_syste | 0.85114657 |
| 108 | MP0008260_abnormal_autophagy | 0.84841813 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.84118259 |
| 110 | MP0005389_reproductive_system_phenotype | 0.83831771 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.81462119 |
| 112 | MP0000598_abnormal_liver_morphology | 0.79377249 |
| 113 | MP0000462_abnormal_digestive_system | 0.79342705 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.78870333 |
| 115 | MP0000750_abnormal_muscle_regeneration | 0.77979449 |
| 116 | MP0008775_abnormal_heart_ventricle | 0.77908925 |
| 117 | MP0002006_tumorigenesis | 0.77500137 |
| 118 | MP0003183_abnormal_peptide_metabolism | 0.77352875 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.76195518 |
| 120 | MP0000343_altered_response_to | 0.76157461 |
| 121 | MP0003699_abnormal_female_reproductive | 0.75983156 |
| 122 | MP0005379_endocrine/exocrine_gland_phen | 0.74917544 |
| 123 | MP0005620_abnormal_muscle_contractility | 0.74521915 |
| 124 | MP0000383_abnormal_hair_follicle | 0.72790255 |
| 125 | MP0001929_abnormal_gametogenesis | 0.72043051 |
| 126 | MP0000013_abnormal_adipose_tissue | 0.71874414 |
| 127 | MP0005310_abnormal_salivary_gland | 0.71604020 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.70819433 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.69791346 |
| 130 | MP0002127_abnormal_cardiovascular_syste | 0.69293193 |
| 131 | MP0001661_extended_life_span | 0.68887491 |
| 132 | MP0006138_congestive_heart_failure | 0.68795810 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.68199099 |
| 134 | MP0009642_abnormal_blood_homeostasis | 0.68082588 |
| 135 | MP0002102_abnormal_ear_morphology | 0.67674235 |
| 136 | MP0002106_abnormal_muscle_physiology | 0.67355724 |
| 137 | MP0008877_abnormal_DNA_methylation | 0.66010451 |
| 138 | MP0005623_abnormal_meninges_morphology | 0.65964224 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.65259209 |
| 140 | MP0003941_abnormal_skin_development | 0.64998853 |
| 141 | MP0006035_abnormal_mitochondrial_morpho | 0.64472688 |
| 142 | MP0005666_abnormal_adipose_tissue | 0.64397818 |
| 143 | MP0002332_abnormal_exercise_endurance | 0.63892950 |
| 144 | MP0001346_abnormal_lacrimal_gland | 0.63874564 |
| 145 | MP0004036_abnormal_muscle_relaxation | 0.63596556 |
| 146 | MP0003890_abnormal_embryonic-extraembry | 0.62704684 |
| 147 | MP0005266_abnormal_metabolism | 0.62521544 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.62518532 |
| 149 | MP0009384_cardiac_valve_regurgitation | 0.61891485 |
| 150 | MP0005535_abnormal_body_temperature | 0.61508376 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.60515828 |
| 152 | MP0003724_increased_susceptibility_to | 0.60229986 |
| 153 | MP0010678_abnormal_skin_adnexa | 0.59312844 |
| 154 | MP0001119_abnormal_female_reproductive | 0.58876349 |
| 155 | MP0005220_abnormal_exocrine_pancreas | 0.57788000 |
| 156 | MP0005551_abnormal_eye_electrophysiolog | 0.56977243 |
| 157 | MP0005334_abnormal_fat_pad | 0.55115407 |
| 158 | MP0001756_abnormal_urination | 0.54729554 |
| 159 | MP0003632_abnormal_nervous_system | 0.53050436 |
| 160 | MP0001542_abnormal_bone_strength | 0.52825807 |
| 161 | MP0002136_abnormal_kidney_physiology | 0.48771087 |
| 162 | MP0000579_abnormal_nail_morphology | 0.47539411 |
| 163 | MP0002229_neurodegeneration | 0.44888155 |
| 164 | MP0004742_abnormal_vestibular_system | 0.43478977 |
| 165 | MP0001765_abnormal_ion_homeostasis | 0.40458770 |
| 166 | MP0001851_eye_inflammation | 0.40281076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.89828666 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.89239879 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 5.66931793 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.13255953 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 4.88460755 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.78020041 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.58397041 |
| 8 | Xanthomatosis (HP:0000991) | 4.41199766 |
| 9 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.29664643 |
| 10 | Subaortic stenosis (HP:0001682) | 4.29664643 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.94568971 |
| 12 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.83791917 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.81839547 |
| 14 | Abnormality of methionine metabolism (HP:0010901) | 3.70429717 |
| 15 | Fat malabsorption (HP:0002630) | 3.68691703 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.67890747 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.65156035 |
| 18 | Complement deficiency (HP:0004431) | 3.59871860 |
| 19 | Asymmetric septal hypertrophy (HP:0001670) | 3.56203752 |
| 20 | Hyperglycinuria (HP:0003108) | 3.54557578 |
| 21 | Hyperglycinemia (HP:0002154) | 3.53580041 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.51738458 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.51738458 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.50536010 |
| 25 | Hyperammonemia (HP:0001987) | 3.46475079 |
| 26 | Ketosis (HP:0001946) | 3.36575603 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34293064 |
| 28 | Sudden death (HP:0001699) | 3.33208329 |
| 29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31596254 |
| 30 | Medial flaring of the eyebrow (HP:0010747) | 3.30039897 |
| 31 | Abnormality of the calf musculature (HP:0001430) | 3.26503851 |
| 32 | Joint hemorrhage (HP:0005261) | 3.26236706 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.25525265 |
| 34 | Steatorrhea (HP:0002570) | 3.21758057 |
| 35 | Tubulointerstitial nephritis (HP:0001970) | 3.20937607 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.07862819 |
| 37 | Spastic paraparesis (HP:0002313) | 3.06055824 |
| 38 | Abnormality of the renal cortex (HP:0011035) | 2.99669030 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 2.99078388 |
| 40 | Hypothermia (HP:0002045) | 2.93855588 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 2.93471743 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.89760974 |
| 43 | Hypolipoproteinemia (HP:0010981) | 2.88361554 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.85598068 |
| 45 | Epidermoid cyst (HP:0200040) | 2.84350025 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.81289273 |
| 47 | Lethargy (HP:0001254) | 2.81009697 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.79285816 |
| 49 | Ketoacidosis (HP:0001993) | 2.77083228 |
| 50 | Proximal tubulopathy (HP:0000114) | 2.74996171 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.74881895 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.74881895 |
| 53 | Hypoglycemic seizures (HP:0002173) | 2.74514317 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.74224506 |
| 55 | Gowers sign (HP:0003391) | 2.73415886 |
| 56 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.72209824 |
| 57 | Congenital primary aphakia (HP:0007707) | 2.71247469 |
| 58 | Glycosuria (HP:0003076) | 2.69858179 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.69858179 |
| 60 | Hypoalphalipoproteinemia (HP:0003233) | 2.67574005 |
| 61 | Progressive macrocephaly (HP:0004481) | 2.65755607 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.60493743 |
| 63 | Neurofibrillary tangles (HP:0002185) | 2.59701231 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.59086008 |
| 65 | Increased serum pyruvate (HP:0003542) | 2.59086008 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.55272355 |
| 67 | Supernumerary spleens (HP:0009799) | 2.54901514 |
| 68 | Gout (HP:0001997) | 2.54251332 |
| 69 | Cerebral edema (HP:0002181) | 2.50055090 |
| 70 | Metabolic acidosis (HP:0001942) | 2.47824960 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45462252 |
| 72 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.45237827 |
| 73 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.45237827 |
| 74 | Short tibia (HP:0005736) | 2.43849360 |
| 75 | Gait imbalance (HP:0002141) | 2.38752889 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.37100520 |
| 77 | Palpebral edema (HP:0100540) | 2.36858495 |
| 78 | Abnormality of complement system (HP:0005339) | 2.36238000 |
| 79 | Renal cortical cysts (HP:0000803) | 2.35328486 |
| 80 | Gonadotropin excess (HP:0000837) | 2.35282472 |
| 81 | Sensory axonal neuropathy (HP:0003390) | 2.34422915 |
| 82 | Myotonia (HP:0002486) | 2.32297527 |
| 83 | Alkalosis (HP:0001948) | 2.30595060 |
| 84 | Metaphyseal dysplasia (HP:0100255) | 2.29892904 |
| 85 | Acute encephalopathy (HP:0006846) | 2.28024740 |
| 86 | Pheochromocytoma (HP:0002666) | 2.27993808 |
| 87 | Parakeratosis (HP:0001036) | 2.26092787 |
| 88 | Nausea (HP:0002018) | 2.24565872 |
| 89 | Thick nail (HP:0001805) | 2.24264953 |
| 90 | Hemiparesis (HP:0001269) | 2.23969059 |
| 91 | Increased purine levels (HP:0004368) | 2.23150668 |
| 92 | Hyperuricemia (HP:0002149) | 2.23150668 |
| 93 | Hepatic necrosis (HP:0002605) | 2.22973926 |
| 94 | Abnormal biliary tract morphology (HP:0012440) | 2.22871791 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 2.21694297 |
| 96 | Nephrogenic diabetes insipidus (HP:0009806) | 2.21269462 |
| 97 | Papillary thyroid carcinoma (HP:0002895) | 2.19809062 |
| 98 | Median cleft lip (HP:0000161) | 2.18909661 |
| 99 | Left ventricular hypertrophy (HP:0001712) | 2.18233740 |
| 100 | Skin nodule (HP:0200036) | 2.16429052 |
| 101 | Abnormal gallbladder morphology (HP:0012437) | 2.14715185 |
| 102 | Poor suck (HP:0002033) | 2.13842316 |
| 103 | Adrenal hypoplasia (HP:0000835) | 2.13644602 |
| 104 | Conjunctival hamartoma (HP:0100780) | 2.12395399 |
| 105 | Tubulointerstitial abnormality (HP:0001969) | 2.12090116 |
| 106 | Neuroendocrine neoplasm (HP:0100634) | 2.12000121 |
| 107 | Brushfield spots (HP:0001088) | 2.10513252 |
| 108 | Spontaneous abortion (HP:0005268) | 2.10100822 |
| 109 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09948325 |
| 110 | Paraparesis (HP:0002385) | 2.09703845 |
| 111 | Pancreatic fibrosis (HP:0100732) | 2.08621640 |
| 112 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.08583254 |
| 113 | Hypercholesterolemia (HP:0003124) | 2.07496071 |
| 114 | Hamartoma of the eye (HP:0010568) | 2.06615489 |
| 115 | Axonal loss (HP:0003447) | 2.06374340 |
| 116 | Thyroid carcinoma (HP:0002890) | 2.05974795 |
| 117 | Genital tract atresia (HP:0001827) | 2.05761643 |
| 118 | Neck muscle weakness (HP:0000467) | 2.05590093 |
| 119 | Rhinitis (HP:0012384) | 2.05417339 |
| 120 | Methylmalonic acidemia (HP:0002912) | 2.05214394 |
| 121 | Irritability (HP:0000737) | 2.04948317 |
| 122 | Abnormal biliary tract physiology (HP:0012439) | 2.04096442 |
| 123 | Bile duct proliferation (HP:0001408) | 2.04096442 |
| 124 | Abolished electroretinogram (ERG) (HP:0000550) | 2.03026004 |
| 125 | Symptomatic seizures (HP:0011145) | 2.02992524 |
| 126 | Malnutrition (HP:0004395) | 2.02080922 |
| 127 | Hemorrhage of the eye (HP:0011885) | 2.00886155 |
| 128 | Vomiting (HP:0002013) | 2.00675890 |
| 129 | Orthostatic hypotension (HP:0001278) | 2.00374097 |
| 130 | Acanthocytosis (HP:0001927) | 1.99412819 |
| 131 | Hypokalemic alkalosis (HP:0001949) | 1.99001487 |
| 132 | Hematochezia (HP:0002573) | 1.98503845 |
| 133 | 3-Methylglutaconic aciduria (HP:0003535) | 1.96967809 |
| 134 | Vascular calcification (HP:0004934) | 1.90121622 |
| 135 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.89779418 |
| 136 | Renal Fanconi syndrome (HP:0001994) | 1.89429856 |
| 137 | Pancreatitis (HP:0001733) | 1.89107238 |
| 138 | Ventricular arrhythmia (HP:0004308) | 1.88391100 |
| 139 | Metabolic alkalosis (HP:0200114) | 1.88213380 |
| 140 | Abnormal gallbladder physiology (HP:0012438) | 1.87057473 |
| 141 | Cholecystitis (HP:0001082) | 1.87057473 |
| 142 | Cholelithiasis (HP:0001081) | 1.86507674 |
| 143 | Vascular tortuosity (HP:0004948) | 1.85730666 |
| 144 | Increased corneal curvature (HP:0100692) | 1.85611535 |
| 145 | Keratoconus (HP:0000563) | 1.85611535 |
| 146 | Opisthotonus (HP:0002179) | 1.85016345 |
| 147 | Prolonged QT interval (HP:0001657) | 1.84911142 |
| 148 | Methylmalonic aciduria (HP:0012120) | 1.83412124 |
| 149 | Systemic lupus erythematosus (HP:0002725) | 1.82425999 |
| 150 | Lipid accumulation in hepatocytes (HP:0006561) | 1.81540233 |
| 151 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80637473 |
| 152 | Abnormality of vitamin metabolism (HP:0100508) | 1.79977006 |
| 153 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.79820029 |
| 154 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.79820029 |
| 155 | Abnormal protein glycosylation (HP:0012346) | 1.79820029 |
| 156 | Abnormal glycosylation (HP:0012345) | 1.79820029 |
| 157 | Prolonged neonatal jaundice (HP:0006579) | 1.78401923 |
| 158 | Elevated hepatic transaminases (HP:0002910) | 1.78061288 |
| 159 | Ependymoma (HP:0002888) | 1.78020085 |
| 160 | Erythroderma (HP:0001019) | 1.77209077 |
| 161 | Hypochromic microcytic anemia (HP:0004840) | 1.76821156 |
| 162 | Increased CSF lactate (HP:0002490) | 1.76574877 |
| 163 | Arterial tortuosity (HP:0005116) | 1.75881708 |
| 164 | Colon cancer (HP:0003003) | 1.75592221 |
| 165 | Abnormality of midbrain morphology (HP:0002418) | 1.75390764 |
| 166 | Molar tooth sign on MRI (HP:0002419) | 1.75390764 |
| 167 | Upper limb muscle weakness (HP:0003484) | 1.75085892 |
| 168 | Hepatocellular carcinoma (HP:0001402) | 1.75037737 |
| 169 | Vaginal atresia (HP:0000148) | 1.74916299 |
| 170 | Increased muscle lipid content (HP:0009058) | 1.74306918 |
| 171 | Postaxial foot polydactyly (HP:0001830) | 1.73771675 |
| 172 | Popliteal pterygium (HP:0009756) | 1.72278535 |
| 173 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.70344512 |
| 174 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.70266247 |
| 175 | Increased CSF protein (HP:0002922) | 1.68215378 |
| 176 | Abnormality of vitamin B metabolism (HP:0004340) | 1.67986676 |
| 177 | Intestinal atresia (HP:0011100) | 1.67521249 |
| 178 | Mitochondrial inheritance (HP:0001427) | 1.66811044 |
| 179 | Reduced antithrombin III activity (HP:0001976) | 1.66569754 |
| 180 | Clitoromegaly (HP:0000057) | 1.66500890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.77661974 |
| 2 | MAP4K2 | 3.71658592 |
| 3 | NEK9 | 3.31334471 |
| 4 | ERBB4 | 3.11544648 |
| 5 | BCKDK | 3.08632366 |
| 6 | MUSK | 2.87662675 |
| 7 | STK38L | 2.83507028 |
| 8 | STK39 | 2.81619664 |
| 9 | MAP3K13 | 2.74821159 |
| 10 | OXSR1 | 2.72932572 |
| 11 | CCNB1 | 2.67777860 |
| 12 | BLK | 2.62481662 |
| 13 | EIF2AK3 | 2.48529639 |
| 14 | IRAK3 | 2.32535761 |
| 15 | IRAK4 | 2.14774598 |
| 16 | PLK2 | 2.13663347 |
| 17 | AKT3 | 2.06990462 |
| 18 | MOS | 2.04322787 |
| 19 | LATS1 | 1.98959457 |
| 20 | IRAK2 | 1.92301361 |
| 21 | MAP3K4 | 1.77239237 |
| 22 | EPHB1 | 1.75927426 |
| 23 | INSRR | 1.73297178 |
| 24 | TAOK1 | 1.72470167 |
| 25 | PLK4 | 1.70918408 |
| 26 | MAP3K6 | 1.62487626 |
| 27 | IRAK1 | 1.60797576 |
| 28 | SCYL2 | 1.53214944 |
| 29 | NEK6 | 1.48854551 |
| 30 | FER | 1.48221239 |
| 31 | MAPKAPK5 | 1.46247040 |
| 32 | BCR | 1.46140972 |
| 33 | PBK | 1.43325032 |
| 34 | PIK3CA | 1.43279067 |
| 35 | WNK4 | 1.42112843 |
| 36 | ARAF | 1.40985639 |
| 37 | GRK7 | 1.39902080 |
| 38 | PINK1 | 1.36899443 |
| 39 | BMPR2 | 1.34952197 |
| 40 | DYRK2 | 1.30875546 |
| 41 | BRAF | 1.28295387 |
| 42 | ACVR1B | 1.25755463 |
| 43 | ERBB3 | 1.22110203 |
| 44 | PRKAA2 | 1.18929363 |
| 45 | PKN1 | 1.18505357 |
| 46 | STK10 | 1.17814878 |
| 47 | MAPK11 | 1.17450032 |
| 48 | PRKCE | 1.14502690 |
| 49 | BMPR1B | 1.13760398 |
| 50 | SGK223 | 1.13137531 |
| 51 | SGK494 | 1.13137531 |
| 52 | LIMK1 | 1.08599908 |
| 53 | MAP3K2 | 1.06262988 |
| 54 | MAP3K3 | 1.05324536 |
| 55 | PDK2 | 1.02501258 |
| 56 | DMPK | 1.02370396 |
| 57 | MYLK | 1.01883977 |
| 58 | NEK1 | 1.01517731 |
| 59 | CSNK1G1 | 1.01000545 |
| 60 | CDK19 | 1.00070720 |
| 61 | MET | 0.99883540 |
| 62 | CDK9 | 0.99545249 |
| 63 | PNCK | 0.98980890 |
| 64 | CSNK1G3 | 0.96037107 |
| 65 | JAK2 | 0.94349067 |
| 66 | TRIM28 | 0.94288732 |
| 67 | FGFR4 | 0.90891349 |
| 68 | BRSK2 | 0.90704269 |
| 69 | CASK | 0.89441764 |
| 70 | TGFBR2 | 0.86345963 |
| 71 | ABL2 | 0.86241673 |
| 72 | NUAK1 | 0.85698082 |
| 73 | TTK | 0.83460345 |
| 74 | PLK3 | 0.83417019 |
| 75 | CAMK2G | 0.83181565 |
| 76 | PIM2 | 0.81907136 |
| 77 | CSNK1A1L | 0.80271803 |
| 78 | VRK1 | 0.79270588 |
| 79 | PIK3CG | 0.79242295 |
| 80 | FGFR2 | 0.79063755 |
| 81 | LMTK2 | 0.77384066 |
| 82 | KSR2 | 0.77348075 |
| 83 | ERN1 | 0.77308090 |
| 84 | EPHB2 | 0.76828671 |
| 85 | SIK1 | 0.75169314 |
| 86 | MELK | 0.74405730 |
| 87 | CDK3 | 0.73863621 |
| 88 | DYRK3 | 0.71151300 |
| 89 | CDK8 | 0.69262437 |
| 90 | WEE1 | 0.69134426 |
| 91 | STK3 | 0.68868936 |
| 92 | TESK2 | 0.68392214 |
| 93 | MAP2K7 | 0.68080025 |
| 94 | MAP3K7 | 0.66578697 |
| 95 | SRPK1 | 0.66572634 |
| 96 | MAP3K14 | 0.66542658 |
| 97 | TYK2 | 0.66503227 |
| 98 | MAPK15 | 0.65464279 |
| 99 | RAF1 | 0.65336336 |
| 100 | GRK1 | 0.65314632 |
| 101 | STK4 | 0.65105845 |
| 102 | FLT3 | 0.63530088 |
| 103 | IKBKE | 0.62306508 |
| 104 | CSNK1G2 | 0.61309093 |
| 105 | ZAK | 0.59055826 |
| 106 | PAK6 | 0.56769901 |
| 107 | PRKAA1 | 0.56570241 |
| 108 | PRKCQ | 0.55410796 |
| 109 | NLK | 0.53782035 |
| 110 | FRK | 0.53332926 |
| 111 | TNIK | 0.53321658 |
| 112 | OBSCN | 0.52674975 |
| 113 | PRKCI | 0.52550193 |
| 114 | PLK1 | 0.52103369 |
| 115 | PRKACB | 0.50770378 |
| 116 | BUB1 | 0.49932124 |
| 117 | MAP3K12 | 0.49665338 |
| 118 | FGFR1 | 0.49389141 |
| 119 | CAMK1D | 0.49296112 |
| 120 | CAMK2A | 0.48549494 |
| 121 | ADRBK2 | 0.47322597 |
| 122 | CAMK2D | 0.46738422 |
| 123 | MST4 | 0.45800175 |
| 124 | EIF2AK2 | 0.44861570 |
| 125 | PDPK1 | 0.44085773 |
| 126 | HIPK2 | 0.43718640 |
| 127 | MAPK7 | 0.42394213 |
| 128 | JAK1 | 0.41385632 |
| 129 | LATS2 | 0.40998379 |
| 130 | KIT | 0.39205199 |
| 131 | MAPK4 | 0.38832459 |
| 132 | TIE1 | 0.37134166 |
| 133 | NME1 | 0.36858516 |
| 134 | PRKG1 | 0.36768922 |
| 135 | EGFR | 0.36533419 |
| 136 | PRKCG | 0.36342361 |
| 137 | RPS6KA5 | 0.35887285 |
| 138 | EPHA3 | 0.35816487 |
| 139 | WNK3 | 0.34809950 |
| 140 | CSNK1D | 0.34512777 |
| 141 | STK16 | 0.34241161 |
| 142 | PIM1 | 0.32658511 |
| 143 | CHEK2 | 0.32044124 |
| 144 | PTK2B | 0.31509679 |
| 145 | ABL1 | 0.31342789 |
| 146 | EIF2AK1 | 0.31180049 |
| 147 | SGK2 | 0.30974432 |
| 148 | TESK1 | 0.29096773 |
| 149 | KSR1 | 0.28529988 |
| 150 | YES1 | 0.27341298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.54077951 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75199066 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74741542 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.69798097 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.66704866 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.63100635 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.59530585 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54362073 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.43518250 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36919106 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34345522 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.31344086 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30186893 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24656212 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.17634161 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15914917 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.15496540 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.12961075 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.12783362 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06756351 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99906469 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99221071 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91153335 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88358474 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.80675868 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79321096 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76924528 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65281089 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63400322 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63392574 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56486758 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.51039503 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50039614 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49144580 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48769973 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44546262 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44138533 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41519017 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40473071 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.38400950 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29854435 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.29464354 |
| 43 | Mismatch repair_Homo sapiens_hsa03430 | 1.29250332 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.29165897 |
| 45 | Proteasome_Homo sapiens_hsa03050 | 1.24575317 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23603666 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22676449 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22591455 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21607276 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19011182 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16649979 |
| 52 | Protein export_Homo sapiens_hsa03060 | 1.15682654 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13820988 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11826686 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07116289 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05716217 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.03007033 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96301936 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90394639 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89797140 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86774507 |
| 62 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.86446115 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.85505376 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85259480 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85124600 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83010315 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78979725 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78663781 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77085975 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72966236 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71283577 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69148403 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68724674 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65373279 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63759442 |
| 76 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63310738 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61860369 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58500759 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58433158 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56091392 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54622689 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54210906 |
| 83 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.54012488 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53654797 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49582227 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49345345 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.47850643 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47405518 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47059356 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.45489580 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42434505 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41968534 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40184488 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39498236 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36699374 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.36672169 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36043853 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.35391617 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.33489487 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.31762262 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29659762 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.29269514 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28795562 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25899170 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25237825 |
| 106 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23593522 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.23061424 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20331395 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.20095175 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13311897 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.11644681 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.08473308 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.04504217 |
| 114 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.03751055 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.02125201 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.00772155 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | -0.0701110 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0638383 |
| 119 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0563568 |
| 120 | Non-homologous end-joining_Homo sapiens_hsa03450 | -0.0543548 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0537241 |
| 122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0511873 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | -0.0502141 |

